1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) is sponsored by National Institutes of Health. Funds pilot research to adapt, optimize, and test behavioral sleep interventions for adolescents and young adults (ages 12-25) with or at risk for mental health disorders, evaluating feasibility, acceptability, and impact on sleep and mental health outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) | Research Funding National Institutes of Health Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) NIMH seeks applications for pilot research to adapt, optimize, and test behavioral interventions that address common sleep problems in adolescents and young adults with or at risk for a mental health disorder.
This notice of funding opportunity (NOFO) supports pilot clinical trials designed to evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the approach in real world settings.
Applications should aim to conduct a preliminary test of the intervention's impact on sleep and mental health outcomes, as well as an examination of the mechanisms that underlie the intervention's effectiveness, and to obtain preliminary data needed as a prerequisite for larger-scale effectiveness trials.
In addition, interdisciplinary, collaborative teams of investigators from the fields of mental health, sleep medicine, developmental science, clinical trials research methods, behavioral economics, implementation science, data science, and human computer interaction are encouraged. Direct costs are limited to $450,000 over the entire project period, with no more than $225,000 in direct costs in any single year.
The scope of the proposed project should determine the project period. The maximum project period is 3 years. Medical - Clinical Science
According to the current listing, eligibility includes: Institutions of higher education and other eligible research organizations. Confirm the full requirements in the official notice before applying.
The current listing shows up to $450,000 direct costs over 3 years; NIMH intends $1.5 million total for up to 6 awards. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) are due October 22, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) is funded by National Institutes of Health. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article